Over one billion people smoke cigarettes globally. This habit is the leading cause for eight million preventable deaths yearly. Vaping was then positioned as a tool to reduce or quit smoking, having brought new pros and cons toward public health efforts. What then, could be used to help people quit vaping?
I began vaping at age 14 and became addicted for 5 years before inventing the CAPNOS Zero. Upon recognizing the existence of sensory dependencies for a tactile, auditory, and aromatic experience, I knew products like CAPNOS had to be brought to market.
While attending a class at Michigan State University, I decided to inhale from my sports bottle cap, which contained a silicone valve. In that moment, saw a future in which millions of people could potentially quit vaping. I became obsessed with testing my hypothesis with CAPNOS.
I launched CAPNOS as a graduating senior in college, selling out our first batch of the Zero. The Zero was selling like hotcakes, and customers wanted an easier hit device, so the E-Z was launched in December. Our core team was established this year.
Retail expansion fell through. Team members had to go. Fundraising didn’t work out. Despite that, our customers remained loyal, sharing requests for a premium device line. The Legura® and BRE-Z launched to market this year.
Utility patents are granted in China and in the European Union. A pilot study has been completed in a laboratory setting. CAPNOS continues to reach new heights as a bootstrapped company by constantly investing in the brand and product experience.